Bart Jessen

1.8k total citations
46 papers, 1.4k citations indexed

About

Bart Jessen is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bart Jessen has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cell Biology. Recurrent topics in Bart Jessen's work include Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (6 papers) and Microtubule and mitosis dynamics (5 papers). Bart Jessen is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (6 papers) and Microtubule and mitosis dynamics (5 papers). Bart Jessen collaborates with scholars based in United States, United Kingdom and Switzerland. Bart Jessen's co-authors include Shuyan Lu, Yvonne Will, Sashi Nadanaciva, Tae Sung, Wenyue Hu, William D. Pennie, David F. Gebhard, Robert H. Rice, Brad Hirakawa and Joseph Jamieson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Bart Jessen

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Jessen United States 19 534 476 242 222 198 46 1.4k
Hao Yan China 24 807 1.5× 324 0.7× 216 0.9× 188 0.8× 446 2.3× 83 1.8k
Shaoyu Yan United States 25 910 1.7× 595 1.3× 421 1.7× 166 0.7× 115 0.6× 39 1.9k
Sangbin Lim South Korea 18 793 1.5× 505 1.1× 311 1.3× 335 1.5× 147 0.7× 32 1.6k
Kumaravelu Jagavelu India 20 620 1.2× 218 0.5× 128 0.5× 260 1.2× 311 1.6× 59 1.4k
Sinéad Toomey Ireland 19 714 1.3× 494 1.0× 253 1.0× 231 1.0× 236 1.2× 66 2.0k
Jisheng Yang United States 14 513 1.0× 186 0.4× 153 0.6× 136 0.6× 121 0.6× 26 1.4k
Noriyuki Koyama Japan 24 821 1.5× 346 0.7× 233 1.0× 189 0.9× 237 1.2× 64 2.1k
Xiaoping Wang United States 19 560 1.0× 413 0.9× 145 0.6× 307 1.4× 104 0.5× 46 1.3k
Lijun Di China 25 1.0k 2.0× 602 1.3× 188 0.8× 236 1.1× 163 0.8× 102 1.9k
Jörg Hoffmann Germany 16 1.0k 1.9× 327 0.7× 121 0.5× 245 1.1× 218 1.1× 27 1.9k

Countries citing papers authored by Bart Jessen

Since Specialization
Citations

This map shows the geographic impact of Bart Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Jessen more than expected).

Fields of papers citing papers by Bart Jessen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Jessen. The network helps show where Bart Jessen may publish in the future.

Co-authorship network of co-authors of Bart Jessen

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Jessen. A scholar is included among the top collaborators of Bart Jessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Jessen. Bart Jessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jessen, Bart, Benno Rattel, David H. Ackley, et al.. (2025). Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs – an IQ DruSafe industry survey. Regulatory Toxicology and Pharmacology. 162. 105902–105902.
2.
Al-Khami, Amir A., Sawsan Youssef, Yasmina Abdiche, et al.. (2020). Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody. Molecular Cancer Therapeutics. 19(10). 2105–2116. 11 indexed citations
3.
Thibault, Stéphane, Wenyue Hu, Brad Hirakawa, et al.. (2018). Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology. Molecular Cancer Therapeutics. 18(2). 257–266. 23 indexed citations
4.
Lu, Shuyan, Tae Sung, Nianwei Lin, Robert T. Abraham, & Bart Jessen. (2017). Lysosomal adaptation: How cells respond to lysosomotropic compounds. PLoS ONE. 12(3). e0173771–e0173771. 109 indexed citations
5.
Hu, Wenyue, Tae Sung, Bart Jessen, et al.. (2015). Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies. Clinical Cancer Research. 22(8). 2000–2008. 132 indexed citations
6.
Sokolowski, Sharon, et al.. (2015). Contribution of Membrane Trafficking Perturbation to Retinal Toxicity. Toxicological Sciences. 145(2). 383–395. 11 indexed citations
7.
Chen, Shihao, Li‐Fen Lee, Timothy S. Fisher, et al.. (2014). Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model. Cancer Immunology Research. 3(2). 149–160. 207 indexed citations
8.
Yanochko, Gina M., Timothy Affolter, Mark Evans, et al.. (2014). Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 30(5). 429–439. 11 indexed citations
9.
Jessen, Bart, et al.. (2013). The Contribution of Lysosomotropism to Autophagy Perturbation. PLoS ONE. 8(11). e82481–e82481. 48 indexed citations
10.
Jessen, Bart, et al.. (2013). Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits. Journal of Ocular Pharmacology and Therapeutics. 29(6). 574–585. 9 indexed citations
11.
Heyen, Jonathan R., Wenyue Hu, Joseph Jamieson, et al.. (2013). Cardiovascular differentiation of imatinib and bosutinib in the rat. International Journal of Hematology. 98(5). 597–607. 3 indexed citations
12.
Huang, Wenhu, et al.. (2012). Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against RTP801 for the Treatment of Ocular Disease. Journal of Ocular Pharmacology and Therapeutics. 28(3). 222–230. 18 indexed citations
13.
Hu, Wenyue, Shuyan Lu, Indrawan McAlpine, et al.. (2012). Mechanistic Investigation of Imatinib-Induced Cardiac Toxicity and the Involvement of c-Abl Kinase. Toxicological Sciences. 129(1). 188–199. 33 indexed citations
14.
Hu, Wenyue, et al.. (2011). Transient knock down of checkpoint kinase 1 in hematopoietic progenitors is linked to bone marrow toxicity. Toxicology Letters. 204(2-3). 141–147. 3 indexed citations
15.
Jessen, Bart, et al.. (2011). Off‐target immune cell toxicity caused by AG‐012986, a pan‐CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation. Journal of Biochemical and Molecular Toxicology. 26(3). 101–108. 7 indexed citations
16.
Yanochko, Gina M., et al.. (2010). Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells. Toxicology in Vitro. 24(4). 1324–1331. 14 indexed citations
17.
Bhat, Balkrishen, Husam S. Younis, Bernadette Pascual, et al.. (2007). Antisense inhibition of 11βhydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model. Biochemical and Biophysical Research Communications. 365(4). 740–745. 9 indexed citations
18.
Jessen, Bart. (2003). Assessment of Hepatocytes and Liver Slices as in Vitro Test Systems to Predict in Vivo Gene Expression. Toxicological Sciences. 75(1). 208–222. 34 indexed citations
19.
Jessen, Bart, Qin Qin, Marjorie A. Phillips, Donald L. Phillips, & Robert H. Rice. (2001). Keratinocyte Differentiation Marker Suppression by Arsenic: Mediation by AP1 Response Elements and Antagonism by Tetradecanoylphorbol Acetate. Toxicology and Applied Pharmacology. 174(3). 302–311. 27 indexed citations
20.
Mariniello, Loredana, Qin Qin, Bart Jessen, & Robert H. Rice. (1995). Keratinocyte Transglutaminase Promoter Analysis:. Journal of Biological Chemistry. 270(52). 31358–31363. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Yan Breakdown of academic impact, for papers by Shaoyu Yan Breakdown of academic impact, for papers by Sangbin Lim Breakdown of academic impact, for papers by Kumaravelu Jagavelu Breakdown of academic impact, for papers by Sinéad Toomey Breakdown of academic impact, for papers by Jisheng Yang Breakdown of academic impact, for papers by Noriyuki Koyama Breakdown of academic impact, for papers by Xiaoping Wang Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Jörg Hoffmann
Rankless by CCL
2026